Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses

An isolated nucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule having a nucleotide sequence which is at least 90% identical to the nucleotide sequence of any of SEQ ID NOs:
• 1, and 3, and the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438, or a complement thereof;
• b) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 2, and 4, and the amino acid sequence encoded by the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438;
• c) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 2, and 4, and the amino acid sequence encoded by the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438, wherein the fragment comprises at least 10 consecutive amino acid residues of any of SEQ ID NOs:
• 2, and 4, and the amino acid sequence encoded by the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 2, and 4, and the amino acid sequence encoded by the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438, wherein the fragment comprises consecutive amino acid residues corresponding to at least half of the full length of any of SEQ ID NOs:2, and 4, and the amino acid sequence encoded by the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438;
• and
• e) a nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 2, and 4, wherein the nucleic acid molecule hybridizes with a nucleic acid molecule consisting of the nucleotide sequence of any of SEQ ID NOs:1, and 3, and the nucleotide sequence of the clone deposited as ATCC® Accession number PTA-438, or a complement thereof under stringent conditions.